CBD, amitriptyline and tramadol drug-drug interaction study

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508428-36-00

Acronym

CHDR2335

Enrollment

Registered

2023-12-14

Start date

2023-12-19

Completion date

2024-03-12

Last updated

2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological assessments

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026